Recruitment specialist Trialbee snags a deal with AstraZeneca

Trialbee, a Swedish patient-recruitment outfit, has added AstraZeneca ($AZN) to its client roster, bringing its direct-to-patient technology to the U.K. drugmaker. Trialbee's platform allows sponsors to tap into online patient groups and scout for potential trial participants, connecting them with motivated patients and potentially bolstering rates of retention and compliance. The deal follows a similar alliance with Novo Nordisk ($NVO). Story

Suggested Articles

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.